Education
About Us
Working with TipRanks
Follow Us
Johnson & Johnson (DE:JNJ)
XETRA:JNJ
Earnings Data
Report Date
Oct 21, 2025Before Open (Confirmed)
Period Ending
2025 (Q3)Consensus EPS Forecast
2.35Last Year’s EPS
2.07Same Quarter Last Year
Moderate Buy
Based on 18 Analysts Ratings
Earnings Call Summary
Earnings Call Sentiment|Positive
The earnings call presented a strong performance in several key areas, including oncology and cardiovascular segments, and raised financial guidance for the year. However, challenges such as the significant impact of STELARA's loss of exclusivity and declines in specific segments like orthopedics were noted. Overall, the highlights slightly outweigh the lowlights.Company Guidance -
Q3 2025
Operational Sales Growth
Johnson & Johnson reported an operational sales growth of 4.6% across its business in the second quarter, with the Innovative Medicines segment delivering 3.8% growth and MedTech achieving 6.1% growth.
Oncology Segment Performance
The oncology division reported operational sales growth of 22.3%, driven by multiple myeloma treatments and significant growth in prostate and lung cancer segments.
MedTech Cardiovascular Growth
The MedTech cardiovascular segment reported over 22% operational sales growth, driven by new product performance in Abiomed and Shockwave, and strength in electrophysiology.
Raised Financial Guidance
Johnson & Johnson raised its full-year sales guidance by $2 billion and EPS guidance by $0.25, from $10.60 to $10.85.
DE:JNJ Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
DE:JNJ Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
Jul 16, 2025 | €133.50 | €140.98 | +5.60% |
Apr 15, 2025 | €134.31 | €135.23 | +0.68% |
Jan 22, 2025 | €140.29 | €135.88 | -3.14% |
Oct 15, 2024 | €144.44 | €146.63 | +1.51% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
FAQ
When does Johnson & Johnson (DE:JNJ) report earnings?
Johnson & Johnson (DE:JNJ) is schdueled to report earning on Oct 21, 2025, Before Open (Confirmed).
What is Johnson & Johnson (DE:JNJ) earnings time?
Johnson & Johnson (DE:JNJ) earnings time is at Oct 21, 2025, Before Open (Confirmed).
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is the P/E ratio of Johnson & Johnson stock?
The P/E ratio of Johnson & Johnson is N/A.
What is DE:JNJ EPS forecast?
DE:JNJ EPS forecast for the fiscal quarter 2025 (Q3) is 2.35.
